atenolol has been researched along with Dementia in 4 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An amlodipine-based BP regimen reduced the long-term incidence of stroke compared with an atenolol-based regimen but had no measurable effect on dementia." | 4.02 | Long-Term Incidence of Stroke and Dementia in ASCOT. ( Godec, T; Gupta, AK; Mackay, J; Rostamian, S; Sever, PS; Whitehouse, A; Whiteley, WN, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Whiteley, WN | 1 |
| Gupta, AK | 1 |
| Godec, T | 1 |
| Rostamian, S | 1 |
| Whitehouse, A | 1 |
| Mackay, J | 1 |
| Sever, PS | 1 |
| Prince, M | 1 |
| Lewis, G | 1 |
| Bird, A | 1 |
| Blizard, R | 1 |
| Mann, A | 1 |
| Curb, JD | 1 |
| Pressel, SL | 1 |
| Cutler, JA | 1 |
| Savage, PJ | 1 |
| Applegate, WB | 2 |
| Black, H | 1 |
| Camel, G | 1 |
| Davis, BR | 1 |
| Frost, PH | 1 |
| Gonzalez, N | 1 |
| Guthrie, G | 1 |
| Oberman, A | 1 |
| Rutan, GH | 1 |
| Stamler, J | 1 |
| Di Bari, M | 1 |
| Pahor, M | 1 |
| Franse, LV | 1 |
| Shorr, RI | 1 |
| Wan, JY | 1 |
| Ferrucci, L | 1 |
| Somes, GW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000514] | Phase 3 | 0 participants | Interventional | 1984-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for atenolol and Dementia
| Article | Year |
|---|---|
A longitudinal study of factors predicting change in cognitive test scores over time, in an older hypertensive population.
Topics: Aged; Amiloride; Antihypertensive Agents; Atenolol; Cognition Disorders; Dementia; Drug Combinations | 1996 |
Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Chlor | 1996 |
Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial.
Topics: Aged; Antihypertensive Agents; Atenolol; Bias; Chlorthalidone; Dementia; Disabled Persons; Double-Bl | 2001 |
1 other study available for atenolol and Dementia
| Article | Year |
|---|---|
Long-Term Incidence of Stroke and Dementia in ASCOT.
Topics: Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Atorvastatin; Cholest | 2021 |